Renal Denervation Systems Market

Renal Denervation Systems Market by Technology (Ultrasound. RF, Microinfusion), Product (Single Electrode Catheter, Neurve Modifying Agents), Application (Heart Failure, Hypertension, Diabetes), End User (Hospitals, Ambulatory Care) - Forecasts to 2022

Report Code: UC 1822 Dec, 2018, by marketsandmarkets.com

The global renal denervation systems market is poised to witness a steady growth during the forecast period. This is expected to be driven by major factors such as rising prevalence of hypertension, increasing geriatric population, clinical advantages such as fast recovery time with minimal complications, technological advancements to develop alternative technologies. Moreover, increasing clinical trials to validate clinical efficacy of renal denervation and cost effectiveness of the procedure over conventional surgeries are expected to offer high growth opportunities for players active in the global renal denervation systems market.

However, stringent regulatory guidelines for product approval in specific countries are expected to hamper the optimal market growth for renal denervation systems during the forecast period.

As of 2016, Medtronic, Plc. Boston Scientific Corporation, St. Jude Medical, Inc., ReCor Medical, Inc., Cordis Corporation, and Terumo Corporation are some of the key players present in global renal denervation systems market. Over the past three years, these companies adopted new product development and launches, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.

Scope of the Report

This research report categorizes renal denervation systems market into the following segments and subsegments:

Renal denervation systems Market, by Technology

  • Ultrasound Ablation
  • Radiofrequency Ablation
  • Pharmacologic Ablation
  • Microinfusion

Renal denervation systems Market, by Products

  • Catheters
  • Single Electrode Catheter
  • Multi Electrode Catheter
  • RF Generator
  • Nerve modifying agents

Renal denervation systems Market, by Disease Application

  • Hypertension
  • Heart failure
  • Diabetes
  • Renal failure
  • Other applications

Renal denervation systems Market, by End User

  • Diagnostic Centers and Hospitals
  • Research & academia
  • Ambulatory Care Centers

Renal denervation systems Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Research Limitations
    1.6 Major Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1.1 Bottom-Up Approach
           2.2.1.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Major Market Drivers
           5.2.2 Major Market Restraints
           5.2.3 Key Growth Opportunities
           5.2.4 Major Market Challenges

6 Renal Denervation Systems Market Value Data, By Technology, USD Million (2015-2022)*
    6.1 Introduction
    6.2 Ultrasound Ablation
    6.3 Radiofrequency Ablation
    6.4 Pharmacologic Ablation
    6.5 Microinfusion

7 Renal Denervation Systems Market Value Data, By Products, USD Million (2015-2022)*
    7.1 Introduction
    7.2 Catheters
           7.2.1 Single Electrode Catheter
           7.2.2 Multi Electrode Catheter
    7.3 RF Generator
    7.4 Nerve Modifying Agents

8 Renal Denervation Systems Market Value Data, By Disease Application, USD Million (2015-2022)*
    8.1 Introduction
    8.2 Hypertension
    8.3 Cardiac Disorders
    8.4 Diabetes
    8.5 Renal Failure
    8.6 Other Applications

9 Renal Denervation Systems Market Value Data, By End User, USD Million (2015-2022)*
    9.1 Introduction
    9.2 Diagnostic Centers and Hospitals 
    9.3 Research & Academia
    9.3 Ambulatory Care Centers

10 Renal Denervation Systems Market Value Data, By Region, USD Million (2015-2022)
     10.1 Introduction
     10.2 North America
     10.3 Europe
     10.4 Asia-Pacific
     10.5 Rest of the World**

11 Competitive Landscape
     11.1 Overview
     11.2 Vendor Inclusion Criteria
     11.3 Competitive Leadership Mapping 
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Competitive Benchmarking 
             11.4.1 Analysis of Product Portfolio of Major Players in the Market (25 Players)
             11.4.2 Business Strategies Adopted By Major Players in the Market (25 Players)
     11.5 Global Market Ranking Analysis (2016)

12 Company Profiles***
     12.1 Introduction
             12.1.1 Geographic Benchmarking
     12.2 Medtronic Inc
             12.2.1 Business Overview
             12.2.2 Products Offered
             12.2.3 Recent Developments (2014-2017)
     12.3 Boston Scientific Corporation.
             12.3.1 Business Overview
             12.3.2 Products Offered
             12.3.3 Recent Developments (2014-2017)
     12.4 St. Jude Medical
             12.4.1 Business Overview
             12.4.2 Products Offered
             12.4.3 Recent Developments (2014-2017)
     12.5 Recor Medical, Inc.,
             12.5.1 Business Overview
             12.5.2 Products Offered
             12.5.3 Recent Developments (2014-2017)
     12.6 Cordis Corporation
             12.6.1 Business Overview
             12.6.2 Products Offered
             12.6.3 Recent Developments (2014-2017)
     12.7 Terumo Corporation
             12.7.1 Business Overview
             12.7.2 Products Offered
             12.7.3 Recent Developments (2014-2017)
     12.8 Mercator Medsystems, Inc
             12.8.1 Business Overview
             12.8.2 Products Offered
             12.8.3 Recent Developments (2014-2017)
     12.9 Kona Medical, Inc
             12.9.1 Business Overview
             12.9.2 Products Offered
             12.9.3 Recent Developments (2014-2017)
     12.10 Cardiosonic Ltd
             12.10.1 Business Overview
             12.10.2 Products Offered
             12.10.3 Recent Developments (2014-2017)
     12.11 Covidien PLC.
             12.11.1 Business Overview
             12.11.2 Products Offered
             12.11.3 Recent Developments (2014-2017)
     12.12 Ablative Solutions, Inc..
             12.12.1 Business Overview
             12.12.2 Products Offered
             12.12.3 Recent Developments (2014-2017)
     12.13 Renal Dynamics Limited.
             12.13.1 Business Overview
             12.13.2 Products Offered
             12.13.3 Recent Developments (2014-2017)
     12.14 Bioscience Webster Inc. .
             12.14.1 Business Overview
             12.14.2 Products Offered
             12.14.3 Recent Developments (2014-2017)
     12.15 Hansen Medical.
             12.15.1 Business Overview
             12.15.2 Products Offered
             12.15.3 Recent Developments (2014-2017)

13 Appendix
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarketsí Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1822
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Renal Denervation Systems Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved